Cancers, Vol. 15, Pages 862: Green Tea in Reproductive Cancers: Could Treatment Be as Simple?
ful Islam
Green tea originates from the tea plant Camellia sinensis and is one of the most widely consumed beverages worldwide. Green tea polyphenols, commonly known as catechins, are the major bioactive ingredients and account for green tea’s unique health benefits. Epigallocatechin-3-gallate (EGCG), is the most potent catechin derivative and has been widely studied for its pro- and anti-oxidative effects. This review summarizes the chemical and chemopreventive properties of green tea in the context of female reproductive cancers. A comprehensive search of PubMed and Google Scholar up to December 2022 wa...
Source: Cancers - January 30, 2023 Category: Cancer & Oncology Authors: Maclaine Parish Gaelle Massoud Dana Hazimeh James Segars Md Soriful Islam Tags: Review Source Type: research
Cancers, Vol. 15, Pages 831: Groin Surveillance by Serial Ultrasonography Rather Than Sentinel Node Biopsy or Inguinofemoral Lymphadenectomy for Patients with Vulvar Cancer: A Pilot Study
as Obermair
A pilot study was conducted to determine whether 3-monthly groin ultrasonography could eliminate groin dissection after a negative bilateral groin ultrasound in three groups of patients: (i) Those with a unifocal stage 1B squamous cell carcinoma of up to 20 mm in diameter. (ii) Those with an ipsilateral squamous cell carcinoma of any size which extended to within 1 cm either side of the midline. These patients underwent ipsilateral inguinofemoral lymphadenectomy and ultrasonic surveillance of the contralateral groin. (iii) Patients with multifocal invasive lesions with the largest individual focus 20 mm or ...
Source: Cancers - January 29, 2023 Category: Cancer & Oncology Authors: Neville F. Hacker Ellen L. Barlow Glenn McNally Stephen Morrell Val Gebski Andreas Obermair Tags: Article Source Type: research
MTA1 as negative prognostic marker in vulvar carcinoma
CONCLUSIONS: MTA1 was identified as a negative prognostic marker for vulvar carcinoma associated with advanced tumor stage and FIGO grading. A possible explanation could be that the antibody used for this study does not bind to a possible mutation in the C terminal region of MTA leading to negative immunohistochemical staining and this can be correlated with early recurrence in patients with vulvar carcinoma.PMID:36689059 | DOI:10.1007/s00432-023-04579-4 (Source: Clinical Breast Cancer)
Source: Clinical Breast Cancer - January 23, 2023 Category: Cancer & Oncology Authors: Giulia Wanka Julia Jueckstock Carl Mathis Wild Aurelia Vattai Sophie F ürst Helene H Heidegger Christina Kuhn Elisa Schmoeckel Udo Jeschke Christian Dannecker Source Type: research
MTA1 as negative prognostic marker in vulvar carcinoma
CONCLUSIONS: MTA1 was identified as a negative prognostic marker for vulvar carcinoma associated with advanced tumor stage and FIGO grading. A possible explanation could be that the antibody used for this study does not bind to a possible mutation in the C terminal region of MTA leading to negative immunohistochemical staining and this can be correlated with early recurrence in patients with vulvar carcinoma.PMID:36689059 | DOI:10.1007/s00432-023-04579-4 (Source: Clinical Genitourinary Cancer)
Source: Clinical Genitourinary Cancer - January 23, 2023 Category: Cancer & Oncology Authors: Giulia Wanka Julia Jueckstock Carl Mathis Wild Aurelia Vattai Sophie F ürst Helene H Heidegger Christina Kuhn Elisa Schmoeckel Udo Jeschke Christian Dannecker Source Type: research
MTA1 as negative prognostic marker in vulvar carcinoma
CONCLUSIONS: MTA1 was identified as a negative prognostic marker for vulvar carcinoma associated with advanced tumor stage and FIGO grading. A possible explanation could be that the antibody used for this study does not bind to a possible mutation in the C terminal region of MTA leading to negative immunohistochemical staining and this can be correlated with early recurrence in patients with vulvar carcinoma.PMID:36689059 | DOI:10.1007/s00432-023-04579-4 (Source: Clin Med Res)
Source: Clin Med Res - January 23, 2023 Category: Research Authors: Giulia Wanka Julia Jueckstock Carl Mathis Wild Aurelia Vattai Sophie F ürst Helene H Heidegger Christina Kuhn Elisa Schmoeckel Udo Jeschke Christian Dannecker Source Type: research
